Advertisement

Topics

Stratify Genomics, Inc. Launches Prompt®, a Genetic Test for Predisposition to Prostate Cancer

16:49 EDT 4 Oct 2018 | Businesswire

This article has expired, however you can still download the PDF.
Preview:
Launched on 9/15, San Diego’s Stratify Genomics, Inc. announced Prompt®, a test to evaluate a man’s genetic predisposition to prostate cancer, designed to provide knowledge of an individual’s baseline prostate cancer risk...

Other Sources for this Article

Sean Curry
c3 Communications, Inc.
scurry@c3publicrelations.com

NEXT ARTICLE

More From BioPortfolio on "Stratify Genomics, Inc. Launches Prompt®, a Genetic Test for Predisposition to Prostate Cancer"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

Prostate Cancer
Prostate cancer (cancer de prostata) Prostate cancer (cancer de prostata) is a form of cancer that develops in the prostate, a gland in the male reproductive system. Most prostate cancers are slow growing; however, there are cases of aggressive prostat...

Cancer Disease
Cancer is not just one disease but many diseases. There are more than 100 different types of cancer. Most cancers are named for the organ or type of cell in which they start - for example, cancer that begins in the colon is called colon cancer; cancer th...